He further stated that the the center will be constructed by IPP Research, Technology and Innovation Limited, one of his companies operating under the IPP Group of Companies.
Mengi also told the conference in Tanzania’s commercial capital, Dar es Salaam, “The center is likely to house a state-of-the art laboratory which at the same time will be used as a treatment center for genetic and metabolic diseases.”
Mengi said a proposal for the licensing of the center is waiting for approval of the National Institute for Medical Research (NIMR).
An international conference on genomic and proteomic and medical innovation was held in Tanzania which was attended by experts from countries such as Egypt, Vietnam, Thailand, the United States, and Nigeria.
Deputy Minister for Health, Faustine Ndungulile praised Mengi for coming up with the idea to establish the center, saying the government will fully support him.
Ndungulile has reportedly directed NIMR officials to fast-track the approval process.
Mengi said construction of the research center is planned to start early next month.
